Stock Price
666.20
Daily Change
-19.20 -2.80%
Monthly
10.81%
Yearly
24.34%
Q2 Forecast
651.81

argenx SE reported $5.83B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
AstraZeneca USD 28.72B 1.22B Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
UCB EUR 6.05B 733M Dec/2025